Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe
2011

Genetic Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe

Sample size: 424 publication Evidence: moderate

Author Information

Author(s): Emmanuelle Génin, Martin Schumacher, Jean-Claude Roujeau, Luigi Naldi, Yvonne Liss, Rémi Kazma, Peggy Sekula, Alain Hovnanian, Maja Mockenhaupt

Primary Institution: Inserm U946, Paris, France

Hypothesis

To investigate genetic association at a genome-wide level on a large sample of SJS/TEN patients.

Conclusion

The study confirms the involvement of genetic variants in the HLA region in SJS/TEN among European patients, particularly with allopurinol exposure.

Supporting Evidence

  • Six SNPs in the HLA region showed significant association with SJS/TEN.
  • The haplotype associated with the disease was stronger in patients exposed to allopurinol.
  • The study is the largest collection of SJS/TEN patients to date.

Takeaway

This study looked at the genes of people with a serious skin reaction to drugs and found that certain genes are linked to this condition, especially in those who took a specific medicine called allopurinol.

Methodology

A genome-wide association study was performed on 424 SJS/TEN patients and 1,881 controls, using SNP genotyping and statistical analysis to identify associations.

Potential Biases

Potential bias due to the selection of controls primarily from France and Germany.

Limitations

The study may have missed some genetic variants with important effects, especially those with low frequencies.

Participant Demographics

The sample included 226 males and 337 females, with a majority from France and Germany.

Statistical Information

P-Value

0.019

Confidence Interval

[4.66; 12.98]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1750-1172-6-52

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication